PROVIDER PROFILE · NPI 1104870427

Michael SuMD

PRACTICEOPHTHALMIC CONSULTANTS OF NEW JERSEY, P.C.See all providers at this practice →

OphthalmologyEast Brunswick, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,150

Unique beneficiaries

—

Total services

2,279

Distinct HCPCS

Medicare payment

$162K

Peer benchmark

Total Medicare services vs. 531 Ophthalmology providers in NJ — below median (cohort median 2,470).

PRESCRIBING · PART D · 2024

Total Rx claims

1,359

Beneficiaries

—

Total drug cost

$124K

Distinct drugs

Brand share

30.6%

Top prescribed drugs

Latanoprost294 claims

Prednisolone Acetate164 claims

Cromolyn Sodium134 claims

Dorzolamide Hcl/Timolol Maleat126 claims

Ciprofloxacin Hcl113 claims

QUALITY · MIPS · 2024

Final MIPS score

95.5

Quality

100.0

Cost

74.4

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.86%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$69

Payment records

By payment type

Food and Beverage$69

REFERRAL NETWORK

Where Michael Su's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
New Jersey Eye Center, P.A. Ambulatory Surgical Center · Bergenfield, NJ	11	12

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
New Jersey Eye Center, P.A. Ambulatory Surgical Center · Bergenfield, NJ	25	74
DHAR, MANORAMA	24	63
Lijing Shen Internal Medicine · Edison, NJ	18	28

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history